Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine in knee replacement surgery
ISRCTN54191675Phase 3Completed
- Sponsor
- University of Leeds
- Start
- Nov 2017
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
01
Overview
Phase 3, randomised, single-blind trial in knee osteoarthritis (OA) comparing Liposomal bupivacaine plus bupivacaine hydrochloride with Bupivacaine hydrochloride alone (2 arms). Primary endpoints: Quality of Recovery 40 score at 72 hours and Cumulative daily pain score at rest. Started Nov 2017; status: completed.
02
Drugs
liposomal bupivacainebupivacaine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ISRCTN54191675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN54191675.